ArticleHereditary cancer in clinical practice2021

Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.

Bettina Meiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.